Clinical and laboratory evaluation of patients exposed to neurotoxicants.

Clin Lab Med

Neurentox International, Inc., Washington, DC.

Published: June 1990

For clinicians, toxicologists, and behavioral scientists, the steady contamination of the environment poses dynamic challenges for accurate diagnosis and evaluation of toxic exposure. The purpose of the neurotoxic evaluation is to determine the level of damage a toxic substance has caused to the biochemistry, physiology, and morphology of the central, peripheral, and autonomic nervous systems. A complete clinical neurotoxicologic assessment hinges on a thorough medical and occupational history, physical examination findings, and specific neurologic and neuropsychologic tests as well as laboratory evaluation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

laboratory evaluation
8
clinical laboratory
4
evaluation
4
evaluation patients
4
patients exposed
4
exposed neurotoxicants
4
neurotoxicants clinicians
4
clinicians toxicologists
4
toxicologists behavioral
4
behavioral scientists
4

Similar Publications

The Canadian Genomics Research and Development Initiative for Antimicrobial Resistance (GRDI-AMR) uses a genomics-based approach to understand how health care, food production and the environment contribute to the development of antimicrobial resistance. Integrating genomics contextual data streams across the One Health continuum is challenging because of the diversity in data scope, content and structure. To better enable data harmonization for analyses, a contextual data standard was developed.

View Article and Find Full Text PDF

Outcomes of a transapical edge-to-edge repair system in secondary mitral regurgitation.

J Invasive Cardiol

January 2025

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; NHC Key Laboratory of Ischemic Heart Diseases; Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences; National Clinical Research Center for Interventional Medicine, Shanghai, China.

Objectives: The ValveClamp system (Hanyu Medical Technology) is a novel transcatheter edge-to-edge repair (TEER) system designed for ease of operation; however, there is a lack of data on its application in secondary mitral regurgitation (SMR). The authors report the mid-term outcomes of TEER using the ValveClamp system in SMR.

Methods: The study prospectively analyzed consecutive severe SMR patients who underwent transapical ValveClamp implantation at 10 Chinese centers.

View Article and Find Full Text PDF

Connecting the dots: Low-grade appendiceal mucinous neoplasms and serrated polyps in the appendix.

Am J Clin Pathol

January 2025

Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, United States.

Objective: This study aimed to examine the relationship between low-grade appendiceal mucinous neoplasms (LAMNs) and serrated polyps (SPs) of the appendix, both characterized by KRAS mutations and overlapping morphologic features.

Methods: We analyzed 27 cases of LAMN and 24 cases of SP from archival records, reviewed pathology, and performed molecular analysis on select cases. Four cases initially diagnosed as LAMN were excluded for not meeting diagnostic criteria, and 1 SP case was reclassified as LAMN.

View Article and Find Full Text PDF

Introduction: Multidrug-resistant (MDR) bacteria like Proteus species have led to more prolonged hospitalizations, fewer care choices, higher treatment costs, and even death. The present study aims to evaluate the prevalence of MDR Proteus species in clinical samples and to suggest the best therapeutic options for the MDR Proteus species.

Methodology: Clinical samples were collected randomly from five hospitals in Golestan Province, Iran, from February 2017 to July 2019.

View Article and Find Full Text PDF

Background: Gender is known to have a strong influence on human health and disease. Despite its relevance to treatment and outcome, gender is insufficiently considered in current health research. One hindering factor is the poor representation of gender information in clinical and health (meta) data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!